Milestone Pharmaceuticals MIST
NASDAQ MIST
$1.05 +0.02 (+2.43%)
As of: Aug 21, 2026 · 3:47 PM EDT

Milestone Pharmaceuticals (MIST) Debt Ratio (2023 - 2026)

Milestone Pharmaceuticals' (MIST) quarterly Debt Ratio came in at 0.3 in Q1 2026, down 65.76% YoY from 0.88 in Q1 2025, and down 40.36% on a QoQ basis from 0.5 in Q4 2025.

Milestone Pharmaceuticals (MIST) Debt Ratio (2023 - 2026) Analysis & Trends

Milestone Pharmaceuticals (MIST) has 4 years of Debt Ratio data on file, last reported at 0.3 in Q1 2026.

  • Quarterly Debt Ratio fell 65.76% year-over-year to 0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.3 (down 65.76% YoY) and the FY2025 annual result came in at 0.5, down 28.73% from the prior year.
  • Debt Ratio slipped to 0.3 in Q1 2026, from 0.5 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.16 in Q2 2025 to a low of 0.3 in Q1 2026.
  • A 4-year average of 0.62 and a median of 0.58 in 2024 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2025 — Debt Ratio soared 101.72% — and 2026, when it sank 65.76%.
  • Tracing MIST's Debt Ratio over 4 years: stood at 0.66 in 2023, then rose by 6.81% to 0.71 in 2024, then dropped by 28.73% to 0.5 in 2025, then sank by 40.36% to 0.3 in 2026.
  • The last three Debt Ratio figures came in at 0.3 (Q1 2026), 0.5 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.09 Bn 131.23 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.66 Bn 77.66 Bn 3.93 Bn 0.05
3 Argenx Se 64.86 Bn 59.67 Bn 1.37 Bn -
4 Moderna 58.07 Bn 52.93 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.87 Bn 36.77 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.45 Bn 28.15 Bn 992.69 Mn -
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn 0.03
8 Insmed 27.40 Bn 26.24 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.28 Bn 26.45 Bn - 0.47
10 Milestone Pharmaceuticals 43.53 Mn -127.97 Mn - 0.33

Historic Data

Download Data
DateValue
Jun 30, 2026 0.33
Mar 31, 2026 0.30
Dec 31, 2025 0.50
Sep 30, 2025 0.64
Jun 30, 2025 1.16
Mar 31, 2025 0.88
Dec 31, 2024 0.71
Sep 30, 2024 0.63
Jun 30, 2024 0.58
Mar 31, 2024 0.53
Dec 31, 2023 0.66
Sep 30, 2023 0.56
Jun 30, 2023 0.50
Mar 31, 2023 0.43